EFPIA - NEWSLETTER

EFPIA Newsletter 19 March 2020

#WeWontRest in the fight against COVID-19

18 March 2020 Europe’s COVID-19 battle: supply, support and the search for diagnostics, vaccines, treatments...

In any health emergency from HIV to SARS, Ebola to the coronavirus, attention turns to the research-based biopharmaceutical...

18 March 2020 Europe’s COVID-19 battle: working together to ensure the supply of medicines to the patients...

EFPIA warmly welcomes this week’s adoption of a range of measures aimed at maintaining the free circulation of medicines...

13 March 2020 Tackling COVID-19: EFPIA welcomes proactive and regular dialogue with Commissioners on the...

EFPIA joined a call with Health Commissioner Kyriakides, Commissioner Breton and Commissioner Lenarčič to discuss the...

12 days left to apply for IMI Call21 to find solutions to tackle COVID-19

Videos

#WeWontRest in the fight against COVID 19

As the impact of COVID-19 continues to be felt across the world, the biopharmaceutical industry in Europe remains committed to global efforts to care for those affected, contain the outbreak and develop resources to tackle future outbreaks.

#IMICarryTheTorch

Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments.

What we are reading

Comparative tracker of EU and Global Covid-19 measures 19 March 2020 (Cicero/AMO)

Politico reporting on EFPIA's battle against Covid-19 19 March 2020 (Politico)

Coronavirus: Commission offers financing to innovative vaccines company CureVac 16 March 2020 (European Commission)

COVID-19: developers of medicines or vaccines to benefit from free scientific advice 13 March 2020 (EMA)

EFPIA calls pharma’s COVID-19 efforts ‘unprecedented’ 12 March 2020 (The Pharma Letter)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶